If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very sensitive, ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Though there is no cure for asthma, Avner says there are key treatments available to help manage the condition. These commonly include inhaled medications such as steroids, "which reduce ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

"Because asthma is a highly variable disease with ... Dr. Celedón mentioned that there is a better treatment for the T2-high disease because research has progressed quickly with this variant.

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

Asthma is a chronic lung condition characterised by recurrent attacks of breathlessness, often accompanied by wheezing. Asthma is due to inflammation in the air passages of the lungs, causing ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...